Sponsors do not reject proposals because the work is wrong. They reject them because the document does not answer the three questions an investment committee asks. Here is the structure that does.
“Half of every forecast meeting is spent arguing about whether the numbers are right, not what to do about them.”
The same discovery call supports two arguments. Choosing wrong costs you the room before you reach the scope.
It was not length, price or turnaround time. It was whether the document quantified the cost of doing nothing.
Your pricing model is an argument about who carries delivery risk. Most firms pick one by habit and never revisit it.
Financials, team, investor thesis, metrics, timeline, tech stack, benchmarks, quantified pain. Miss one and the proposal thins out.
Naming what happens if the client does nothing turns a discount conversation into a documented decision.
Scope items that map to a named discipline are easier to price, easier to sequence and much easier to defend.
Role-based cards win reviews that blended day rates lose. The difference is auditability.
Small advisory teams are quicker than mid-market firms, and it is not because they have fewer approvals.
The section nobody reads until it matters. Six patterns that have survived contact with clients' counsel.
New playbooks and research as they publish. No product announcements, no digest, no sequence you have to unsubscribe from twice.